Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iclaprim vs Vancomycin in Gram-Positive Nosocomial Pneumonia
NCT00543608Phase 2Terminated
- Sponsor
- Arpida Ltd
- Start
- Nov 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Iclaprim in hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), Healthcare-associated pneumonia (HCAP), sponsored by Arpida Ltd. Started Nov 2007; status: terminated.
02
Drugs
Iclaprim
03
Conditions
hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)Healthcare-associated pneumonia (HCAP)
Beyond the preview
Go deeper on NCT00543608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543608.